Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, McCullough LE, Zhao S, Torres MA, Wan Y (2025) Pharmacological dissection identifies retatrutide overcomes the therapeutic barrier of obese TNBC treatments through suppressing the interplay between glycosylation and ubiquitylation of YAP
But ShipBob is a stand-up operation, run by stand-up people. Gregory Frye, VP of Operations at Hi-Altitude Brands The evolution weve seen from ShipBob even just this past year has been incredible, and were excited to see where we go next together
Clinical reports and case series have documented instances of retained gastric contents found during anaesthetic induction in patients taking GLP-1 medications who had followed standard fasting instructions
Researchers examined data from adults with a BMI of 27 or higher who started GLP-1 therapy between 2018 and 2023